Multiple sclerosis and COVID‐19: The Swedish experience

The COVID‐19 pandemic has brought challenges for healthcare management of patients with multiple sclerosis (MS). Concerns regarding vulnerability to infections and disease‐modifying therapies (DMTs) and their complications have been raised. Recent published guidelines on the use of DMTs in relation...

Descripción completa

Detalles Bibliográficos
Autores principales: Landtblom, Anne‐Marie, Berntsson, Shala G., Boström, Inger, Iacobaeus, Ellen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222873/
https://www.ncbi.nlm.nih.gov/pubmed/34028810
http://dx.doi.org/10.1111/ane.13453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222873/
https://www.ncbi.nlm.nih.gov/pubmed/34028810
http://dx.doi.org/10.1111/ane.13453

Ejemplares similares